Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-10 10:13 am Sale | 2022-05-09 | 13G | Kaleido Biosciences, Inc. KLDO | FMR LLC | 86,046 0.201% | -6,303,106 (-98.65%) | Filing History |
| 2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | Kaleido Biosciences, Inc. KLDO | FMR LLC | 6,389,152 14.999% | 2,696,593 (+73.03%) | Filing History |
| 2021-02-16 08:00 am Purchase | 2020-12-31 | 13G | Kaleido Biosciences, Inc. KLDO | HarbourVest Partners L.P. | 1,833,832 5.100% | 1,833,832 (New Position) | Filing History |
| 2021-02-10 5:15 pm Purchase | 2021-02-08 | 13D | Kaleido Biosciences, Inc. KLDO | Flagship Ventures Fund V, L.P. | 19,575,710 47.700% | 215,000 (+1.11%) | Filing History |
| 2021-01-11 10:51 am Purchase | 2021-01-08 | 13G | Kaleido Biosciences, Inc. KLDO | FMR LLC | 3,692,559 10.262% | 1,605,652 (+76.94%) | Filing History |
| 2020-06-08 4:30 pm Purchase | 2020-06-04 | 13D | Kaleido Biosciences, Inc. KLDO | Flagship Ventures Fund V, L.P. | 19,360,710 55.000% | 2,000,000 (+11.52%) | Filing History |
| 2020-02-07 11:24 am Purchase | 2020-02-06 | 13G | Kaleido Biosciences, Inc. KLDO | FMR LLC | 2,086,907 6.941% | 2,086,907 (New Position) | Filing History |